ARTA
A.R.T. Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,824
| Closed | -$667K | – | 105 |
|
|
2020
Q4 | $667K | Buy |
+2,824
| New | +$667K | 3.09% | 4 |
|
|
2019
Q4 | – | Sell |
-2,455
| Closed | -$416K | – | 1760 |
|
|
2019
Q3 | $416K | Sell |
2,455
-10,200
| -81% | -$1.73M | 0.02% | 928 |
|
|
2019
Q2 | $2.32M | Sell |
12,655
-300
| -2% | -$55K | 0.13% | 202 |
|
|
2019
Q1 | $2.38M | Sell |
12,955
-21,245
| -62% | -$3.91M | 0.14% | 194 |
|
|
2018
Q4 | $5.67M | Buy |
34,200
+7,100
| +26% | +$1.18M | 0.36% | 36 |
|
|
2018
Q3 | $5.22M | Sell |
27,100
-26,700
| -50% | -$5.15M | 0.24% | 85 |
|
|
2018
Q2 | $9.14M | Sell |
53,800
-33,200
| -38% | -$5.64M | 0.37% | 35 |
|
|
2018
Q1 | $14.2M | Buy |
87,000
+83,600
| +2,459% | +$13.6M | 0.57% | 8 |
|
|
2017
Q4 | $509K | Sell |
3,400
-30,800
| -90% | -$4.61M | 0.02% | 887 |
|
|
2017
Q3 | $5.2M | Sell |
34,200
-6,200
| -15% | -$943K | 0.27% | 71 |
|
|
2017
Q2 | $5.21M | Sell |
40,400
-66,400
| -62% | -$8.56M | 0.28% | 62 |
|
|
2017
Q1 | $11.7M | Buy |
106,800
+70,600
| +195% | +$7.72M | 0.54% | 16 |
|
|
2016
Q4 | $2.67M | Buy |
36,200
+25,200
| +229% | +$1.86M | 0.16% | 180 |
|
|
2016
Q3 | $959K | Sell |
11,000
-3,669
| -25% | -$320K | 0.31% | 76 |
|
|
2016
Q2 | $1.26M | Sell |
14,669
-47,100
| -76% | -$4.05M | 0.06% | 461 |
|
|
2016
Q1 | $4.91M | Buy |
61,769
+11,800
| +24% | +$938K | 0.22% | 102 |
|
|
2015
Q4 | $6.29M | Sell |
49,969
-48,396
| -49% | -$6.09M | 0.3% | 56 |
|
|
2015
Q3 | $10.2M | Buy |
98,365
+60,474
| +160% | +$6.3M | 0.38% | 42 |
|
|
2015
Q2 | $4.68M | Buy |
+37,891
| New | +$4.68M | 0.16% | 169 |
|
|
2014
Q2 | – | Sell |
-88,742
| Closed | -$6.28M | – | 1551 |
|
|
2014
Q1 | $6.28M | Buy |
+88,742
| New | +$6.28M | 0.33% | 59 |
|
|
2013
Q4 | – | Sell |
-98,173
| Closed | -$7.44M | – | 1533 |
|
|
2013
Q3 | $7.44M | Buy |
98,173
+102
| +0.1% | +$7.73K | 0.41% | 27 |
|
|
2013
Q2 | $7.85M | Buy |
+98,071
| New | +$7.85M | 0.26% | 83 |
|